Global Small Molecule CDMO Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12241021

Publication Date:

December 3, 2024

Pages:

158

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Small Molecule CDMO market size was valued at US$ 1136.7 million in 2023. With growing demand in downstream market, the Small Molecule CDMO is forecast to a readjusted size of US$ 2501.9 million by 2030 with a CAGR of 11.9% during review period.
The research report highlights the growth potential of the global Small Molecule CDMO market. Small Molecule CDMO are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Small Molecule CDMO. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Small Molecule CDMO market.
Key Features:
The report on Small Molecule CDMO market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Small Molecule CDMO market. It may include historical data, market segmentation by Type (e.g., Development, API Production), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Small Molecule CDMO market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Small Molecule CDMO market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Small Molecule CDMO industry. This include advancements in Small Molecule CDMO technology, Small Molecule CDMO new entrants, Small Molecule CDMO new investment, and other innovations that are shaping the future of Small Molecule CDMO.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Small Molecule CDMO market. It includes factors influencing customer ' purchasing decisions, preferences for Small Molecule CDMO product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Small Molecule CDMO market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Small Molecule CDMO market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Small Molecule CDMO market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Small Molecule CDMO industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Small Molecule CDMO market.
Market Segmentation:
Small Molecule CDMO market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Development
API Production
Segmentation by application
Pharmaceutical
Biotechnology
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
Catalent
Thermo Fisher
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Jiangsu Sinopep
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Jubilant Pharmova
Consort Medical

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Small Molecule CDMO Market Size 2019-2030
2.1.2 Small Molecule CDMO Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Small Molecule CDMO Segment by Type
2.2.1 Development
2.2.2 API Production
2.3 Small Molecule CDMO Market Size by Type
2.3.1 Small Molecule CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Small Molecule CDMO Market Size Market Share by Type (2019-2024)
2.4 Small Molecule CDMO Segment by Application
2.4.1 Pharmaceutical
2.4.2 Biotechnology
2.5 Small Molecule CDMO Market Size by Application
2.5.1 Small Molecule CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Small Molecule CDMO Market Size Market Share by Application (2019-2024)
3 Small Molecule CDMO Market Size by Player
3.1 Small Molecule CDMO Market Size Market Share by Players
3.1.1 Global Small Molecule CDMO Revenue by Players (2019-2024)
3.1.2 Global Small Molecule CDMO Revenue Market Share by Players (2019-2024)
3.2 Global Small Molecule CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Small Molecule CDMO by Regions
4.1 Small Molecule CDMO Market Size by Regions (2019-2024)
4.2 Americas Small Molecule CDMO Market Size Growth (2019-2024)
4.3 APAC Small Molecule CDMO Market Size Growth (2019-2024)
4.4 Europe Small Molecule CDMO Market Size Growth (2019-2024)
4.5 Middle East & Africa Small Molecule CDMO Market Size Growth (2019-2024)
5 Americas
5.1 Americas Small Molecule CDMO Market Size by Country (2019-2024)
5.2 Americas Small Molecule CDMO Market Size by Type (2019-2024)
5.3 Americas Small Molecule CDMO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Molecule CDMO Market Size by Region (2019-2024)
6.2 APAC Small Molecule CDMO Market Size by Type (2019-2024)
6.3 APAC Small Molecule CDMO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Small Molecule CDMO by Country (2019-2024)
7.2 Europe Small Molecule CDMO Market Size by Type (2019-2024)
7.3 Europe Small Molecule CDMO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Small Molecule CDMO by Region (2019-2024)
8.2 Middle East & Africa Small Molecule CDMO Market Size by Type (2019-2024)
8.3 Middle East & Africa Small Molecule CDMO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Small Molecule CDMO Market Forecast
10.1 Global Small Molecule CDMO Forecast by Regions (2025-2030)
10.1.1 Global Small Molecule CDMO Forecast by Regions (2025-2030)
10.1.2 Americas Small Molecule CDMO Forecast
10.1.3 APAC Small Molecule CDMO Forecast
10.1.4 Europe Small Molecule CDMO Forecast
10.1.5 Middle East & Africa Small Molecule CDMO Forecast
10.2 Americas Small Molecule CDMO Forecast by Country (2025-2030)
10.2.1 United States Small Molecule CDMO Market Forecast
10.2.2 Canada Small Molecule CDMO Market Forecast
10.2.3 Mexico Small Molecule CDMO Market Forecast
10.2.4 Brazil Small Molecule CDMO Market Forecast
10.3 APAC Small Molecule CDMO Forecast by Region (2025-2030)
10.3.1 China Small Molecule CDMO Market Forecast
10.3.2 Japan Small Molecule CDMO Market Forecast
10.3.3 Korea Small Molecule CDMO Market Forecast
10.3.4 Southeast Asia Small Molecule CDMO Market Forecast
10.3.5 India Small Molecule CDMO Market Forecast
10.3.6 Australia Small Molecule CDMO Market Forecast
10.4 Europe Small Molecule CDMO Forecast by Country (2025-2030)
10.4.1 Germany Small Molecule CDMO Market Forecast
10.4.2 France Small Molecule CDMO Market Forecast
10.4.3 UK Small Molecule CDMO Market Forecast
10.4.4 Italy Small Molecule CDMO Market Forecast
10.4.5 Russia Small Molecule CDMO Market Forecast
10.5 Middle East & Africa Small Molecule CDMO Forecast by Region (2025-2030)
10.5.1 Egypt Small Molecule CDMO Market Forecast
10.5.2 South Africa Small Molecule CDMO Market Forecast
10.5.3 Israel Small Molecule CDMO Market Forecast
10.5.4 Turkey Small Molecule CDMO Market Forecast
10.5.5 GCC Countries Small Molecule CDMO Market Forecast
10.6 Global Small Molecule CDMO Forecast by Type (2025-2030)
10.7 Global Small Molecule CDMO Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Small Molecule CDMO Product Offered
11.1.3 Lonza Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Small Molecule CDMO Product Offered
11.2.3 Catalent Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Information
11.3.2 Thermo Fisher Small Molecule CDMO Product Offered
11.3.3 Thermo Fisher Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Main Business Overview
11.3.5 Thermo Fisher Latest Developments
11.4 Wuxi Apptec
11.4.1 Wuxi Apptec Company Information
11.4.2 Wuxi Apptec Small Molecule CDMO Product Offered
11.4.3 Wuxi Apptec Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Wuxi Apptec Main Business Overview
11.4.5 Wuxi Apptec Latest Developments
11.5 PharmaBlock
11.5.1 PharmaBlock Company Information
11.5.2 PharmaBlock Small Molecule CDMO Product Offered
11.5.3 PharmaBlock Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 PharmaBlock Main Business Overview
11.5.5 PharmaBlock Latest Developments
11.6 Asym Chemical
11.6.1 Asym Chemical Company Information
11.6.2 Asym Chemical Small Molecule CDMO Product Offered
11.6.3 Asym Chemical Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Asym Chemical Main Business Overview
11.6.5 Asym Chemical Latest Developments
11.7 Jiuzhou Pharmaceutical
11.7.1 Jiuzhou Pharmaceutical Company Information
11.7.2 Jiuzhou Pharmaceutical Small Molecule CDMO Product Offered
11.7.3 Jiuzhou Pharmaceutical Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Jiuzhou Pharmaceutical Main Business Overview
11.7.5 Jiuzhou Pharmaceutical Latest Developments
11.8 Pharmaron Beijing
11.8.1 Pharmaron Beijing Company Information
11.8.2 Pharmaron Beijing Small Molecule CDMO Product Offered
11.8.3 Pharmaron Beijing Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pharmaron Beijing Main Business Overview
11.8.5 Pharmaron Beijing Latest Developments
11.9 Porton Pharma
11.9.1 Porton Pharma Company Information
11.9.2 Porton Pharma Small Molecule CDMO Product Offered
11.9.3 Porton Pharma Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Porton Pharma Main Business Overview
11.9.5 Porton Pharma Latest Developments
11.10 ChemPartner
11.10.1 ChemPartner Company Information
11.10.2 ChemPartner Small Molecule CDMO Product Offered
11.10.3 ChemPartner Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 ChemPartner Main Business Overview
11.10.5 ChemPartner Latest Developments
11.11 Jiangsu Sinopep
11.11.1 Jiangsu Sinopep Company Information
11.11.2 Jiangsu Sinopep Small Molecule CDMO Product Offered
11.11.3 Jiangsu Sinopep Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Jiangsu Sinopep Main Business Overview
11.11.5 Jiangsu Sinopep Latest Developments
11.12 DELPHARM
11.12.1 DELPHARM Company Information
11.12.2 DELPHARM Small Molecule CDMO Product Offered
11.12.3 DELPHARM Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 DELPHARM Main Business Overview
11.12.5 DELPHARM Latest Developments
11.13 Aenova Group
11.13.1 Aenova Group Company Information
11.13.2 Aenova Group Small Molecule CDMO Product Offered
11.13.3 Aenova Group Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Aenova Group Main Business Overview
11.13.5 Aenova Group Latest Developments
11.14 Siegfried Holding AG
11.14.1 Siegfried Holding AG Company Information
11.14.2 Siegfried Holding AG Small Molecule CDMO Product Offered
11.14.3 Siegfried Holding AG Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Siegfried Holding AG Main Business Overview
11.14.5 Siegfried Holding AG Latest Developments
11.15 Recipharm AB
11.15.1 Recipharm AB Company Information
11.15.2 Recipharm AB Small Molecule CDMO Product Offered
11.15.3 Recipharm AB Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Recipharm AB Main Business Overview
11.15.5 Recipharm AB Latest Developments
11.16 FAREVA SA
11.16.1 FAREVA SA Company Information
11.16.2 FAREVA SA Small Molecule CDMO Product Offered
11.16.3 FAREVA SA Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 FAREVA SA Main Business Overview
11.16.5 FAREVA SA Latest Developments
11.17 Almac Group
11.17.1 Almac Group Company Information
11.17.2 Almac Group Small Molecule CDMO Product Offered
11.17.3 Almac Group Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Almac Group Main Business Overview
11.17.5 Almac Group Latest Developments
11.18 Cambrex
11.18.1 Cambrex Company Information
11.18.2 Cambrex Small Molecule CDMO Product Offered
11.18.3 Cambrex Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Cambrex Main Business Overview
11.18.5 Cambrex Latest Developments
11.19 Charles River
11.19.1 Charles River Company Information
11.19.2 Charles River Small Molecule CDMO Product Offered
11.19.3 Charles River Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Charles River Main Business Overview
11.19.5 Charles River Latest Developments
11.20 CORDEN PHARMA
11.20.1 CORDEN PHARMA Company Information
11.20.2 CORDEN PHARMA Small Molecule CDMO Product Offered
11.20.3 CORDEN PHARMA Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 CORDEN PHARMA Main Business Overview
11.20.5 CORDEN PHARMA Latest Developments
11.21 Jubilant Pharmova
11.21.1 Jubilant Pharmova Company Information
11.21.2 Jubilant Pharmova Small Molecule CDMO Product Offered
11.21.3 Jubilant Pharmova Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Jubilant Pharmova Main Business Overview
11.21.5 Jubilant Pharmova Latest Developments
11.22 Consort Medical
11.22.1 Consort Medical Company Information
11.22.2 Consort Medical Small Molecule CDMO Product Offered
11.22.3 Consort Medical Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Consort Medical Main Business Overview
11.22.5 Consort Medical Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂